PL BioScience
PrivateLast Round
Series A
Aug 12, 2024
Total Funding Raised
$13.06M
Company Overview
PL BioScience operates in Healthcare & Life Sciences and is based in Aachen. Its latest recorded funding round was a Series A round in August 2024.
PL BioScience is a biotechnology company that develops and manufactures animal-free cell culture media, specifically Human Platelet Lysate (HPL), for use in regenerative medicine, cell therapy, and biopharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PL BioScience Comparables
Compare PL BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mill Creek Life Sciences | 87% | |
| AventaCell BioMedical Corp. | 86% | |
| Compass Biomedical | 84% |
For institutional investors. Book with your work email.
PL BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 12, 2024 | ||||
| Seed | May 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PL BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BORN2GROW | Seed |
| Better Ventures | Series A |
| better ventures | Series A |
| Born2grow | Seed |
| Tech Vision Fonds | Series A |
| Brightlands Venture Partners | Series A, Seed |
| Federal Ministry for Economic Affairs and Energy | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Exclusive agreement with Summit Pharmaceuticals International Corporation for the Japanese market.
- Dec 22, 2025
Added Iwai Chem, a chemicals/life sciences distributor, as a customer.
For institutional investors. Book with your work email.
PL BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PL BioScience's valuation, stock price, and market status.
Is PL BioScience a public or private company?
PL BioScience is a private company.
What is the current stock price of PL BioScience?
PL BioScience is a private company, so its shares have no public market price. Caplight tracks PL BioScience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PL BioScience worth (valuation)?
Valuation information for PL BioScience is not publicly available.
Can I buy PL BioScience stock?
PL BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PL BioScience's last funding round?
PL BioScience's most recent funding round was Series A on August 12, 2024.
Who are the main investors in PL BioScience?
Key investors in PL BioScience include Better Ventures, b.value AG, AVANT BIO.
Will PL BioScience IPO soon?
No public IPO plans have been announced for PL BioScience.
How can I track PL BioScience secondary market activity?
Caplight tracks bids, offers, and trades in PL BioScience's shares on secondary markets.